Cosmetic cross-reference

Bemiparin

CAS 9041-08-1

Bemiparin (CAS 9041-08-1) is a pharmaceutical compound with 0 bioactivity targets and 3,434 adverse event associations.

SOURCE NLM DailyMed

Label records

SOURCE EMBL-EBI ChEMBL

Bioactivity

SOURCE DrugCentral

Adverse signals

3,434

SOURCE IUPHAR/BPS

PubMed IDs

SOURCE DrugCentral 055904D152D6

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name

Bemiparin

CAS Number

9041-08-1

UNII

PUE0TO3XDR

ChEMBL ID

CHEMBL1201414

DrugCentral Struct ID

4840

Source Match

DrugCentral (CAS), FDA GSRS (UNII)

Synonyms and normalized names

DALTEPARIN SODIUM

SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →

SOURCE DrugCentral 80 associations

Adverse Event Associations

DrugCentral / FAERS disproportionality signal rows matched to this compound.

Reaction PT	Drug AE	LLR	MedDRA
Pulmonary embolism	562	434.927	10037377
Appendicolith	163	410.827	10074458
General physical health deterioration	650	345.254	10049438
Drug ineffective	244	336.271	10013709
Device operational issue	63	272.265	10079315
Appendicitis	169	270.654	10003011
Needle issue	148	260.287	10069217
Hepatocellular injury	219	258.811	10019837
Thrombocytopenia	565	250.506	10043554
Cardiogenic shock	205	246.986	10007625
Toxic epidermal necrolysis	199	222.534	10044223
Ascites	259	208.93	10003445
Acute kidney injury	757	201.398	10069339
Multiple organ dysfunction syndrome	306	192.625	10077361
Sepsis	510	184.363	10040047
Heparin-induced thrombocytopenia	93	172.563	10062506
Deep vein thrombosis	292	154.361	10051055
Blood phosphorus increased	87	146.683	10050196
Ventricular fibrillation	135	142.4	10047290
Arthralgia	141	140.227	10003239
Anaemia	620	125.043	10002034
Arthropathy	10	123.616	10003285
Hyponatraemia	312	119.74	10021036
Abdominal discomfort	45	111.833	10000059
Therapeutic product effect decreased	7	111.544	10082201
Syringe issue	69	110.14	10069218
Cholestasis	147	110.039	10008635
Pemphigus	3	105.183	10034280
Abdominal distension	246	104.092	10000060
Abdominal pain	530	103.491	10000081
Drug intolerance	50	100.438	10061822
Systemic lupus erythematosus	10	98.865	10042945
Glossodynia	4	98.613	10018388
Treatment failure	18	97.928	10066901
Joint swelling	56	97.315	10023232
Rheumatoid arthritis	29	96.903	10039073
Febrile neutropenia	350	92.968	10016288
Headache	220	89.828	10019211
Constipation	430	89.37	10010774
Hyperkalaemia	209	88.656	10020646
Sinusitis	24	87.128	10040753
Pancytopenia	271	85.478	10033661
Discomfort	8	85.395	10013082
Rash maculo-papular	136	85.241	10037868
Neutropenia	414	83.889	10029354
Product dose omission issue	48	83.878	10084406
Alopecia	60	82.786	10001760
Stress	173	78.156	10042209
Toxicity to various agents	92	76.869	10070863
Drug reaction with eosinophilia and systemic symptoms	137	74.966	10073508

Association rows are source-linked signal records, not incidence rates or clinical causality claims.

SOURCE IUPHAR/BPS 1 interaction

IUPHAR Ligand-Target Data

Curated ligand-target interaction rows with action, affinity, and literature identifiers.

Target	Action	Affinity	PubMed
serpin family C member 1 SERPINC1	Activation	-	3744129

SOURCE NLM RxNorm 2 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

Name	RxCUI	Type	Source
DALTEPARIN SODIUM	82137	SU	MTHSPL
dalteparin sodium	82137	PIN	RXNORM

SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Bemiparin used for in pharmaceutical contexts?

Bemiparin (CAS 9041-08-1) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Bemiparin?

Bemiparin has 3,434 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Pulmonary embolism, Appendicolith, General physical health deterioration, Drug ineffective, Device operational issue. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Bemiparin also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Sodium Heparin with EU status "permitted".

What clinical phase is Bemiparin in?

No phase 1-4 clinical development badge is rendered for Bemiparin because the matched compound identifier rows do not contain a max-phase value.